Please wait

Exhibit 107

Calculation of Filing Fee Tables

424(b)(5)

(Form Type)

Apellis Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1—Newly Registered and Carry Forward Securities

 

    Security
Type		     Security
Class Title		     Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price Per
Unit		   Maximum
Aggregate
Offering Price		   Fee Rate   Amount of
Registration
Fee		   Carry
Forward
Form Type		   Carry
Forward
File
Number		   Carry
Forward
Initial
Effective
Date		   Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward

Newly Registered Securities

Fees to be Paid

     Equity      
 Common Stock, par value
$0.0001 per share		  
 		   457(r)   8,563,830 (1)   47.00   $402,500,010   $92.70

per
$1,000,000

   $37,311.75 (2)   —     —     —     —  

Fees Previously Paid

     —         —       —     —     —     —     —     —     —     —     —     —  

Carry Forward Securities

Carry Forward Securities

     —         —       —     —     —     —     —     —     —     —     —     —  
    Total Offering Amounts     $402,500,010   —     $37,311.75        
    Total Fees Previously Paid         —          
    Total Fee Offsets         —          
    Net Fee Due         $37,311.75        

 

(1)

Includes 1,117,021 shares of common stock issuable upon exercise of the underwriters’ option to purchase additional shares of common stock.

(2)

The registration fee relates to the Registration Statement on Form S-3ASR (File No. 333-235830) filed by the Registrant on January 7, 2020.